Horizon Pharma plc (39) | Business Finance (12)

Browse by Subcategory

Recent Contracts

Third Supplemental Indenture, dated March 15, 2021, by and between Viela Bio, Inc. and U.S. Bank National Association (Filed With SEC on May 5, 2021)
Incremental Amendment and Lender Joinder Agreement, dated August 17, 2020, by and among JP Morgan Chase Bank, N.A., as an incremental revolving lender and as an issuing bank,... (Filed With SEC on November 2, 2020)
Underwriting Agreement, dated August 6, 2020, by and among Horizon Therapeutics Public Limited Company and the several underwriters named therein (Filed With SEC on August 10, 2020)
Release and Waiver of Claims of Robert F. Carey, dated as of September 18, 2019 (Filed With SEC on November 6, 2019)
Horizon Therapeutics Public Limited Company 2014 Non-Employee Equity Plan, as amended, and Form of Option Agreement, Form of Stock Option Grant Notice, Forms of Restricted Stock... (Filed With SEC on May 8, 2019)
Rights Agreement, dated as of February 28, 2019, between Horizon Pharma Public Limited Company and Computershare Trust Company, N.A (Filed With SEC on February 28, 2019)
Second Supplemental Indenture, dated April 23, 2020, by and among Horizon Properties Holding LLC, Curzion Pharmaceuticals, Inc. and U.S. Bank National Association (Filed With SEC on May 6, 2020)
First Supplemental Indenture, dated November 19, 2019, by and between HZNP Finance Limited and U.S. Bank National Association (Filed With SEC on May 6, 2020)
Indenture dated as of July 16, 2019 by and between Horizon Pharma USA, Inc., the guarantors party thereto and U.S. Bank National Association, as trustee (Filed With SEC on July 16, 2019)
Underwriting Agreement, dated March 6, 2019, by and among Horizon Pharma Public Limited Company and the several underwriters named therein (Filed With SEC on March 7, 2019)
Third Supplemental Indenture, dated November 15, 2018, by and between Horizon Medicines LLC and U.S. Bank National Association (Filed With SEC on February 27, 2019)
Seventh Supplemental Indenture, dated November 15, 2018, by and between Horizon Medicines LLC and U.S. Bank National Association (Filed With SEC on February 27, 2019)